However, the observation of a drop in NGB plasma levels in individuals who have progressed from cognitive normal to MCI -which we assume reflects a drop in brain levels-, together with the mice data would imply that NGB is a defensive mechanism during the early phases of Alzheimer’s disease. The gene discussed is NGB; the disease is Alzheimer disease.